TABLE 3

Mapping of l(3)psg2, l(3)psg5, and l(3)psg7

PSG lociAllelesDominant marker mappingEstimated positionCytological deficiencies testedDefined deficiencies tested
l(3)psg22300(Recombination within R and D)∼25Df(3L)BSC23Df(3L)ED4342
152031 ++, 28 R+, 42 + D66C–66DDf(3L)HR119Df(3L)ED210
Df(3L)GN24Df(3L)Exel6104
Df(3L)ZN47Df(3L)Exel6105
Df(3L)XDI98Df(3L)Exel6106
Df(3L)BSC27Df(3L)Exel6107
Df(3L)BSC33Df(3L)Exel7210
Df(3L)pbl-X1Df(3L)ED212
Df(3L)ZP1
Df(3L)66C-G28
Df(3L)h-i22
Df(3L)BSC35
Df(3L)AC1
l(3)psg55307(Recombination within R and D)∼34Df(3L)BSC27Df(3L)Exel6112
92931 ++, 20 R+, 91 + D67E-FDf(3L)BSC33Df(3L)ED4408
Df(3L)pbl-X1Df(3L)Exel6279
Df(3L)ZP1Df(3L)Exel8104
Df(3L)66C-G28
Df(3L)BSC13
Df(3L)h-i22
Df(3L)BSC35
Df(3L)AC1
Df(3L)BSC14
Df(3L)vin5
Df(3L)vin7
l(3)psg76753(Recombination within Sb and H)∼66Df(3R)Cha7Df(3R)Exel6178
141441 ++, 9 Sb+, 23 + H91FDf(3R)DG4
16677Df(3R)LK19-1
  • The three mapped l(3)psg loci are listed on the left along with the alleles that define each lethal complementation group. One example of dominant marker mapping is provided, showing the number of recombinants recovered along with the estimated map position. All cytological and defined deficiencies used to map each locus are listed, with the noncomplementing deficiencies underlined.